Last week, the US Food and Drug Administration approved Zepbound to treat chronic obesity. The injectable drug is made by Eli Lilly and contains the active ingredient tirzepatide. This was approved for type 2 diabetes in May 2022 under the name Mounjaro.

Related Videos :







FDA has just approved Mounjaro as “Zepbound” for treatment of obesity. #Zepbound #FDAapproval [jMmRjDKL3]

FDA has just approved Mounjaro as “Zepbound” for treatment of obesity. #Zepbound #FDAapproval [jMmRjDKL3]

Last week, the US Food and Drug Administration approved Zepbound to treat chronic obesity. The injectable drug is made by Eli Lilly and contains the active ingredient tirzepatide. This was approved for type 2 diabetes in May 2022 under the name Mounjaro.

Related Videos :

Aired: December 3rd 2024

Rating: TV-14

Buy Now:

Problems Playing Video? | Closed Captioning

Learn About Midwifery Today

Blog

Learn About Midwifery Today

Read the Modern Day Midwives Blog and learn more about our bloggers, all experienced midwives.

Read now